Jefferies upgraded Aegerion Pharmaceuticals (NASDAQ: AEGR) from to Buy with a price target of $26.00, citing positive risk/reward.Analyst Eun Yang ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE